Bio-Rad Laboratories (NYSE:BIO.B) Reaches New 12-Month Low – What’s Next?

Bio-Rad Laboratories, Inc. (NYSE:BIO.B)’s share price reached a new 52-week low during mid-day trading on Monday . The stock traded as low as $241.99 and last traded at $241.99, with a volume of 110 shares. The stock had previously closed at $265.82.

Bio-Rad Laboratories Stock Performance

The business’s fifty day moving average price is $302.47 and its 200 day moving average price is $322.98. The company has a quick ratio of 4.85, a current ratio of 6.48 and a debt-to-equity ratio of 0.18. The firm has a market capitalization of $6.78 billion, a PE ratio of -3.72 and a beta of 0.75.

Bio-Rad Laboratories (NYSE:BIO.B) last announced its quarterly earnings data on Thursday, February 13th. The company reported $2.90 EPS for the quarter. Bio-Rad Laboratories had a positive return on equity of 3.90% and a negative net margin of 71.86%.

About Bio-Rad Laboratories

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.